MYCN and neoplasm: Both SF1126 and SF2523, orthogonally hit PI3K and BRD4 signaling, which blocks MYCN expression, activation and promotes MYCN degradation, ultimately leading to reduced tumor growth, angiogenesis and tumor metastasis [22,114,115].